Novo Integrated Sciences Income After Taxes 2012-2024 | NVOS

Novo Integrated Sciences income after taxes from 2012 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Novo Integrated Sciences Annual Income After Taxes
(Millions of US $)
2024 $-16
2023 $-13
2022 $-33
2021 $-4
2020 $-5
2019 $0
2018 $-2
2017 $-1
2016 $0
2016 $0
2015 $-3
2014 $-1
2013 $-1
2012 $-1
2012 $-1
2011 $-2
2011 $-2
Novo Integrated Sciences Quarterly Income After Taxes
(Millions of US $)
2024-08-31 $5
2024-05-31 $-14
2024-02-29 $-3
2023-11-30 $-5
2023-08-31 $-3
2023-05-31 $-1
2023-02-28 $-5
2022-11-30 $-4
2022-08-31 $-23
2022-05-31 $-4
2022-02-28 $-5
2021-11-30 $-2
2021-08-31 $-2
2021-05-31 $0
2021-02-28 $-1
2020-11-30 $-1
2020-08-31 $-4
2020-05-31 $0
2020-02-29 $-1
2019-11-30 $0
2019-08-31 $0
2019-05-31 $0
2019-02-28 $0
2018-11-30 $0
2018-08-31 $0
2018-05-31 $0
2018-02-28 $-1
2017-11-30 $0
2017-08-31 $0
2017-05-31 $0
2017-03-31 $0
2017-02-28 $0
2016-12-31
2016-11-30 $0
2016-09-30 $0
2016-06-30 $0
2016-05-31 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $-2
2014-12-31
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-08-31
2012-06-30 $0
2012-03-31 $0
2012-02-29 $0
2011-12-31
2011-11-30 $-1
2011-09-30 $-1
2011-08-31 $0
2011-06-30 $0
2011-05-31 $-1
2011-03-31 $-1
2011-02-28 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.868B 18.03
Encompass Health (EHC) United States $11.084B 23.50
DaVita (DVA) United States $10.915B 15.35
Elanco Animal Health (ELAN) United States $7.013B 15.02
Chemed (CHE) United States $6.094B 20.33
Option Care Health (OPCH) United States $5.017B 21.28
RadNet (RDNT) United States $4.253B 269.95
Amedisys (AMED) United States $3.239B 20.78
Addus HomeCare (ADUS) United States $1.985B 21.79
LifeStance Health (LFST) United States $1.645B 0.00
Astrana Health (ASTH) United States $1.350B 33.44
U.S Physical Therapy (USPH) United States $1.137B 29.35
Aveanna Healthcare Holdings (AVAH) United States $0.778B 44.33
Pennant (PNTG) United States $0.778B 28.57
Atai Life Sciences (ATAI) Germany $0.695B 0.00
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.035B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00